Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2378

Flagship biotech Valo Health ends 2024 with mid-stage fail

$
0
0
Valo Health’s diabetic retinopathy drug failed to improve patients' symptoms in a Phase 2 study, and the company is now on the hunt for a partner. The company said Tuesday that ...

Viewing all articles
Browse latest Browse all 2378

Trending Articles